Rznomics 썸네일형 리스트형 [Korean News] Korea’s Biopharma Licensing Surges Past KRW 18 Trillion in 2025: A Platform-Technology Revolution Korea’s biopharmaceutical industry has surpassed KRW 18.1 trillion (USD 13+ billion) in outbound technology-licensing deals in 2025, marking the strongest year in its history.According to multiple November 2025 reports from The Korea Economic Daily, Chosun Biz, Seoul Economic Daily, and Newsway, the country has significantly outperformed its previous record of KRW 13.8 trillion set in 2021.Beyon.. 더보기 이전 1 다음
